ImmunoScape
9 articles about ImmunoScape
-
ImmunoScape Leadership to Present at Upcoming March 2024 Industry Conferences
3/1/2024
ImmunoScape, a biotechnology company focused on next-generation T Cell receptor -based immunotherapies, announced that members of its executive team will present at two upcoming conferences, BioCentury-BayHelix East-West Summit 2024 and The State of Precision Medicine 2024.
-
ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to Develop Novel T Cell Receptor-Based Therapeutics
12/21/2023
ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to Develop Novel T Cell Receptor-Based Therapeutics.
-
ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development
12/20/2023
ImmunoScape and MiNK Therapeutics, Inc today announced a collaboration agreement to discover and develop next-generation TCR therapies against novel targets in solid tumors.
-
ImmunoScape Appoints Systems Immunology and Computational Biology Expert Dr. John Tsang to its Scientific Advisory Board
12/12/2023
ImmunoScape, a biotechnology company focused on next-generation immunotherapies, announced the appointment of John Tsang, Ph.D. to its Scientific Advisory Board.
-
ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors
9/20/2022
ImmunoScape, a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR-T-cell therapeutics today announced that it has raised $14M in new financing.
-
ImmunoScape To Present at the 7th Annual CAR-TCR Summit
9/15/2022
ImmunoScape, a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR-T-cell therapeutics, today announced that Dan MacLeod, Ph.D., the company’s vice president of discovery, will present at the 7th Annual CAR-TCR Summit taking place September 19-22, 2022 in Boston.
-
ImmunoScape Expands its Executive and Scientific Teams to Extend Use of its Deep Immunomics Platform into Drug Discovery
6/29/2021
ImmunoScape today announced it has made three strategic additions to its global team to expand the use of its innovative technology platform for drug discovery.
-
BioSpace Movers & Shakers, Feb. 26
2/26/2021
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
ImmunoScape Targets Immunology Breakthroughs for COVID-19 and Oncology with $11M in Global Financing Led by Anzu Partners and UTEC
8/12/2020
The funds enable ImmunoScape to bring its unique immune-profiling capability to major biopharma companies globally, accelerating development of vital immunotherapies and other medicines [12-August-2020] SINGAPORE and SAN DIEGO , Aug. 12, 2020 /PRNewswire/ -- ImmunoScape ( www.ImmunoScape.com ), a biotech firm enabling unprecedented insights into the human immune sys